EPIPODOPHYLLIN DERIVATIVE (VP 16-213) IN MALIGNANT TERATOMAS AND CHORIOCARCINOMAS
Authors:
- E.S. NewlandsENE.S. Newlands
- K.D. BagshaweKBK.D. Bagshawe
- 1 July 1977
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 310 (8028) , 87
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- SURVIVAL AFTER CARDIAC ARREST IN HOSPITALThe Lancet, 1977
- A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213Cancer, 1975
- Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasCancer, 1974
- Experience with 4′-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosisEuropean Journal of Cancer (1965), 1974